Global Dental Filling Material Market Expands Steadily Amid Rising Oral Healthcare Demand Global Dental Filling Material Market is witnessing consistent expansion as oral healthcare gains increasing priority worldwide. Valued at USD 2.8 billion in 2024, the market is projected to grow from USD 2.94 billion in 2025 to approximately USD 4.5 billion by 2031, reflecting a solid compound annual growth rate (CAGR) of 6.3% during the forecast period. This growth trajectory is supported by rising dental caries prevalence, heightened aesthetic awareness, and continuous advancements in restorative dental materials. Access the market report https://www.24lifesciences.com/dental-filling-material-market-8646

Global Tinea Versicolor Treatment Market Shows Steady Expansion Through 2032 Global Tinea Versicolor Treatment Market continues to demonstrate stable growth as awareness, diagnosis, and treatment access improve across both developed and emerging healthcare systems. Valued at USD 732 million in 2024, the market is projected to expand from USD 764 million in 2025 to approximately USD 1,012 million by 2032, registering a compound annual growth rate (CAGR) of 4.1% during the forecast period. This growth reflects sustained demand for effective antifungal therapies addressing one of the most common superficial fungal skin conditions worldwide. Access the market report https://www.24lifesciences.com/tinea-versicolor-treatment-market-9225

Predictive Genetic Testing and Consumer & Wellness Genomics Market Size to Reach USD 10.23 Billion by 2032 Global Predictive Genetic Testing and Consumer & Wellness Genomics Market is undergoing a period of rapid expansion as healthcare systems and individuals increasingly embrace preventive, data-driven health strategies. Valued at USD 3.51 billion in 2024, the market is projected to grow from USD 4.05 billion in 2025 to USD 10.23 billion by 2032, registering a robust CAGR of 14.1% during the forecast period. This growth reflects rising demand for personalized healthcare, early disease risk assessment, and wellness optimization powered by genomic insights. Access the market report https://www.24lifesciences.com/predictive-genetic-testing-and-consumer-wellness-genomics-market-9425

Ultrasound Endoscope Market Size to Reach USD 3.6 Billion by 2032 | Growth Trends & Insights Global ultrasound endoscope market is witnessing steady and technology-driven growth as healthcare systems increasingly prioritize minimally invasive diagnostics and precision-guided interventions. Valued at USD 2.3 billion in 2024, the market is projected to reach USD 3.6 billion by 2032, expanding at a CAGR of 5.8% during the forecast period. This upward trajectory reflects rising procedural volumes, expanding clinical applications, and continuous innovation in endoscopic imaging technologies across both developed and emerging healthcare markets. Ultrasound endoscopes have become indispensable tools in modern medicine, enabling clinicians to combine endoscopic visualization with high-resolution ultrasound imaging to improve diagnostic accuracy and therapeutic outcomes. Access the market report https://www.24lifesciences.com/ultrasound-endoscope-market-9926

What Is the Future of the Gastritis Treatment Market? Growth Forecasts & Insights Global gastritis treatment market is demonstrating consistent growth as gastrointestinal disorders gain greater clinical attention worldwide. Valued at approximately USD 4.5 billion in 2024, the market is projected to expand from USD 4.8 billion in 2025 to USD 6.9 billion by 2031, registering a compound annual growth rate (CAGR) of 5.3% during the forecast period. This upward trajectory is driven by the high prevalence of Helicobacter pylori infection, lifestyle-related risk factors, and increasing reliance on long-term pharmacological management for chronic gastric conditions. Access the report https://www.24lifesciences.com/gastritis-treatment-market-9033

Neuropsychiatric Disorders and Treatment Market Size to Reach USD 211.8 Billion by 2032 Global neuropsychiatric disorders and treatment market is entering a critical phase of expansion as mental health emerges as a central priority for healthcare systems worldwide. Valued at USD 146.5 billion in 2024, the market is projected to grow from USD 153.9 billion in 2025 to USD 211.8 billion by 2032, registering a CAGR of 4.9% over the forecast period. This sustained growth reflects rising diagnosis rates, increasing awareness, and steady innovation across pharmacological and non-pharmacological treatment pathways addressing complex neurological and psychiatric conditions. As societies confront the clinical, economic, and social burden of mental health disorders, neuropsychiatric care is increasingly viewed as a long-term healthcare investment rather than episodic intervention. Access the market report https://www.24lifesciences.com/neuropsychiatric-disorders-and-treatment-market-9553

Hair Loss Treatment Products Market Size to Reach USD 2.86 Billion by 2031 | Growth Insights Global hair loss treatment products market is undergoing steady expansion, supported by rising aesthetic awareness, increasing stress-related alopecia cases, and continuous innovation in dermatological care. Valued at USD 2.14 billion in 2024, the market is projected to reach USD 2.86 billion by 2031, growing at a CAGR of 4.3% during the forecast period. This growth reflects a convergence of medically proven therapies, consumer-driven grooming trends, and broader access to treatment options across both developed and emerging economies. As hair loss increasingly impacts quality of life and self-perception, demand continues to rise for effective, safe, and personalized treatment solutions across men and women globally. Access the market report https://www.24lifesciences.com/hair-loss-treatment-products-market-market-3382

What Is the Future of the Elbow Stiffness Treatment Market? Growth Forecasts & Insights Global elbow stiffness treatment market is witnessing steady expansion as orthopedic care increasingly prioritizes functional recovery and long-term mobility outcomes. Valued at USD 2.1 billion in 2024, the market is projected to grow from USD 2.25 billion in 2025 to USD 3.4 billion by 2031, registering a compound annual growth rate (CAGR) of 6.1% during the forecast period. Growth is driven by rising incidences of post-traumatic injuries, an aging global population, and continuous advancements in both non-surgical and surgical treatment modalities. Access the market report https://www.24lifesciences.com/elbow-stiffness-treatment-market-9047

What Is the Future of the Rheumatic Fever Treatment Market? Growth Forecasts & Insights Global rheumatic fever treatment market continues to play a critical role in addressing preventable cardiovascular complications linked to streptococcal infections. Valued at USD 1.2 billion in 2024, the market is projected to grow from USD 1.25 billion in 2025 to USD 1.8 billion by 2031, expanding at a CAGR of 5.2% during the forecast period. Market expansion is supported by sustained demand for antibiotic prophylaxis, public health prevention programs, and long-term disease management strategies aimed at reducing the global burden of rheumatic heart disease. Access the market report https://www.24lifesciences.com/rheumatic-fever-treatment-market-9064

What Is the Future of the Tyrosine Hydroxylase Deficiency Drugs Market? Growth Forecasts & Insights Global Tyrosine Hydroxylase Deficiency Drugs market is gaining strategic importance within the rare neurological disorders landscape, supported by advancing diagnostics and heightened clinical awareness. Valued at USD 12.5 million in 2024, the market is projected to grow from USD 13.8 million in 2025 to USD 22.1 million by 2032, registering a CAGR of 6.9% during the forecast period. This sustained growth reflects increasing recognition of Tyrosine Hydroxylase Deficiency (THD) as a treatable condition requiring lifelong, specialized therapeutic management. Access the market report https://www.24lifesciences.com/tyrosine-hydroxylase-deficiency-drugs-market-9215